nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A bacterial strain with the deletion of a prophage gene only in the plasmid also showed diminished antibiotic resistance
|
Cho, Yun Young |
|
|
57 |
3 |
p. |
artikel |
2 |
Antibiotic strategies and clinical outcomes for patients with carbapenem-resistant Gram-negative bacterial bloodstream infection
|
Qu, Junyan |
|
|
57 |
3 |
p. |
artikel |
3 |
Azithromycin, a questionable treatment for COVID-19
|
Belfaqeeh, O. |
|
|
57 |
3 |
p. |
artikel |
4 |
Balanced evaluation of preliminary data on a candidate COVID-19 hydroxychloroquine treatment
|
Seligmann, Hervé |
|
|
57 |
3 |
p. |
artikel |
5 |
Chloroquine for treatment of COVID-19 results in subtherapeutic exposure and prolonged QTc intervals
|
Brüggemann, R.J. |
|
|
57 |
3 |
p. |
artikel |
6 |
Combatting the Rising Tide of Antimicrobial Resistance: Pharmacokinetic/Pharmacodynamic Dosing Strategies for Maximal Precision
|
Chua, Hubert C. |
|
|
57 |
3 |
p. |
artikel |
7 |
Comparison of two empirical prolonged infusion dosing regimens for meropenem in patients with septic shock: A two-center pilot study
|
Eisert, Albrecht |
|
|
57 |
3 |
p. |
artikel |
8 |
Co-occurrence of mcr-1 and mcr-8 genes in multi-drug-resistant Klebsiella pneumoniae from a 2015 clinical isolate
|
Hala, S. |
|
|
57 |
3 |
p. |
artikel |
9 |
Determination of vancomycin exposure target and individualised dosing recommendations for neonates: model-informed precision dosing
|
Tang, Zhe |
|
|
57 |
3 |
p. |
artikel |
10 |
Dysbiosis of the rat vagina is efficiently rescued by vaginal microbiota transplantation or probiotic combination
|
Chen, Tingtao |
|
|
57 |
3 |
p. |
artikel |
11 |
Effect of hydroxychloroquine and azithromycin on the viral clearance of SARS-CoV-2: response to Hervé Seligmann
|
Gautret, Philippe |
|
|
57 |
3 |
p. |
artikel |
12 |
Escherichia coli prophage sequences are not present in a carbapenemase plasmid from Klebsiella. Reply to Authors' response to Letter to the Editor: If extraordinary data are not first corroborated, we risk being led astray: Occam's razor does not support the existence of plasmid-prophage chimeras. Comment on ‘Effects of cryptic prophage regions in a plasmid carrying a carbapenemase gene on survival against antibiotic stress’
|
Jobling, Michael G. |
|
|
57 |
3 |
p. |
artikel |
13 |
Evaluating the emergence of nonsusceptibility among Pseudomonas aeruginosa respiratory isolates from a phase-3 clinical trial for treatment of nosocomial pneumonia (ASPECT-NP)
|
Johnson, Matthew G. |
|
|
57 |
3 |
p. |
artikel |
14 |
Genomic analysis of VIM-2-producing Enterobacter hormaechei subsp. steigerwaltii
|
Bonnin, Rémy A. |
|
|
57 |
3 |
p. |
artikel |
15 |
High carriage of ESBL-producing Enterobacteriaceae associated with sexual activity among men who have sex with men
|
van Bilsen, Ward P.H. |
|
|
57 |
3 |
p. |
artikel |
16 |
Inhibition of the replication of SARS-CoV-2 in human cells by the FDA-approved drug chlorpromazine
|
Plaze, Marion |
|
|
57 |
3 |
p. |
artikel |
17 |
International Society of Antimicrobial Chemotherapy (ISAC) News and Information Page
|
|
|
|
57 |
3 |
p. |
artikel |
18 |
In-vitro pharmacokinetic/pharmacodynamic model data suggest a potential role of new formulations of posaconazole against Candida krusei but not Candida glabrata infections
|
Beredaki, Maria-Ioanna |
|
|
57 |
3 |
p. |
artikel |
19 |
Multicenter study of ceftolozane/tazobactam for treatment of Pseudomonas aeruginosa infections in critically ill patients
|
Balandin, Bárbara |
|
|
57 |
3 |
p. |
artikel |
20 |
Outcomes associated with recent guideline recommendations removing metronidazole for treatment of non-severe Clostridioides difficile infection: a retrospective, observational, nationwide cohort study
|
Gentry, Chris A. |
|
|
57 |
3 |
p. |
artikel |
21 |
Passive immunization and its rebirth in the era of the COVID-19 pandemic
|
Pavia, Charles S. |
|
|
57 |
3 |
p. |
artikel |
22 |
Pharmacokinetics of colistin in cerebrospinal fluid after intraventricular administration alone in intracranial infections
|
Ni, Min |
|
|
57 |
3 |
p. |
artikel |
23 |
Pharmacotherapy for Bordetella pertussis infection. I. A synthesis of laboratory sciences
|
Cimolai, Nevio |
|
|
57 |
3 |
p. |
artikel |
24 |
Pharmacotherapy for Bordetella pertussis infection. II. A synthesis of clinical sciences
|
Cimolai, Nevio |
|
|
57 |
3 |
p. |
artikel |
25 |
Reply to the letter to the editor “Azithromycin, treatment in COVID-19”
|
Manafi, Navid |
|
|
57 |
3 |
p. |
artikel |
26 |
Rifampicin and Isoniazid Maximal Concentrations are Below Efficacy-associated Thresholds in the Majority of Patients: Time to Increase the Doses?
|
Trentalange, Alice |
|
|
57 |
3 |
p. |
artikel |
27 |
Seven-year surveillance of the prevalence of antimicrobial-resistant Escherichia coli isolates, with a focus on ST131 clones, among healthy people in Osaka, Japan
|
Fukuda, Akira |
|
|
57 |
3 |
p. |
artikel |
28 |
Short-cycle therapy (5 days on/2 days off) with a lamivudine + dolutegravir regimen in a cohort of virologically suppressed patients with HIV infection
|
Lanzafame, Massimiliano |
|
|
57 |
3 |
p. |
artikel |
29 |
The Novel Membrane-Associated Auxiliary Factors AuxA and AuxB Modulate β-lactam Resistance in MRSA by stabilizing Lipoteichoic Acids
|
Mikkelsen, Kasper |
|
|
57 |
3 |
p. |
artikel |
30 |
Title Page & Editorial Board
|
|
|
|
57 |
3 |
p. |
artikel |